299 related articles for article (PubMed ID: 28255675)
1. Co-localization of the cannabinoid type 1 receptor with corticotropin-releasing factor-containing afferents in the noradrenergic nucleus locus coeruleus: implications for the cognitive limb of the stress response.
R Wyrofsky R; Reyes BAS; Van Bockstaele EJ
Brain Struct Funct; 2017 Sep; 222(7):3007-3023. PubMed ID: 28255675
[TBL] [Abstract][Full Text] [Related]
2. Direct targeting of peptidergic amygdalar neurons by noradrenergic afferents: linking stress-integrative circuitry.
Kravets JL; Reyes BA; Unterwald EM; Van Bockstaele EJ
Brain Struct Funct; 2015 Jan; 220(1):541-58. PubMed ID: 24271021
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing factor is preferentially colocalized with excitatory rather than inhibitory amino acids in axon terminals in the peri-locus coeruleus region.
Valentino RJ; Rudoy C; Saunders A; Liu XB; Van Bockstaele EJ
Neuroscience; 2001; 106(2):375-84. PubMed ID: 11566507
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin-releasing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain.
Van Bockstaele EJ; Colago EE; Valentino RJ
J Comp Neurol; 1996 Jan; 364(3):523-534. PubMed ID: 8820881
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural Characterization of Corticotropin-Releasing Factor and Neuropeptide Y in the Rat Locus Coeruleus: Anatomical Evidence for Putative Interactions.
Theisen CC; Reyes BAS; Sabban EL; Van Bockstaele EJ
Neuroscience; 2018 Aug; 384():21-40. PubMed ID: 29775703
[TBL] [Abstract][Full Text] [Related]
6. Cellular interactions between axon terminals containing endogenous opioid peptides or corticotropin-releasing factor in the rat locus coeruleus and surrounding dorsal pontine tegmentum.
Tjoumakaris SI; Rudoy C; Peoples J; Valentino RJ; Van Bockstaele EJ
J Comp Neurol; 2003 Nov; 466(4):445-56. PubMed ID: 14566941
[TBL] [Abstract][Full Text] [Related]
7. Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: substrate for the co-ordination of emotional and cognitive limbs of the stress response.
Van Bockstaele EJ; Colago EE; Valentino RJ
J Neuroendocrinol; 1998 Oct; 10(10):743-57. PubMed ID: 9792326
[TBL] [Abstract][Full Text] [Related]
8. Localization of the delta opioid receptor and corticotropin-releasing factor in the amygdalar complex: role in anxiety.
Reyes BAS; Kravets JL; Connelly KL; Unterwald EM; Van Bockstaele EJ
Brain Struct Funct; 2017 Mar; 222(2):1007-1026. PubMed ID: 27376372
[TBL] [Abstract][Full Text] [Related]
9. Pro-opiomelanocortin colocalizes with corticotropin- releasing factor in axon terminals of the noradrenergic nucleus locus coeruleus.
Reyes BA; Glaser JD; Magtoto R; Van Bockstaele EJ
Eur J Neurosci; 2006 Apr; 23(8):2067-77. PubMed ID: 16630054
[TBL] [Abstract][Full Text] [Related]
10. A.E. Bennett Research Award. Anatomic basis for differential regulation of the rostrolateral peri-locus coeruleus region by limbic afferents.
Van Bockstaele EJ; Peoples J; Valentino RJ
Biol Psychiatry; 1999 Nov; 46(10):1352-63. PubMed ID: 10578450
[TBL] [Abstract][Full Text] [Related]
11. Amygdalar peptidergic circuits regulating noradrenergic locus coeruleus neurons: linking limbic and arousal centers.
Reyes BA; Carvalho AF; Vakharia K; Van Bockstaele EJ
Exp Neurol; 2011 Jul; 230(1):96-105. PubMed ID: 21515261
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in the effect of cannabinoid type 1 receptor deletion on locus coeruleus-norepinephrine neurons and corticotropin releasing factor-mediated responses.
Wyrofsky RR; Reyes BAS; Yu D; Kirby LG; Van Bockstaele EJ
Eur J Neurosci; 2018 Sep; 48(5):2118-2138. PubMed ID: 30103253
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructure of endomorphin-1 immunoreactivity in the rat dorsal pontine tegmentum: evidence for preferential targeting of peptidergic neurons in Barrington's nucleus rather than catecholaminergic neurons in the peri-locus coeruleus.
Peoples JF; Wessendorf MW; Pierce T; Van Bockstaele EJ
J Comp Neurol; 2002 Jul; 448(3):268-79. PubMed ID: 12115708
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors.
Scavone JL; Mackie K; Van Bockstaele EJ
Brain Res; 2010 Feb; 1312():18-31. PubMed ID: 19931229
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid receptor-immunoreactivity in corticotrophin-releasing factor afferents to the locus coeruleus.
Lechner SM; Valentino RJ
Brain Res; 1999 Jan; 816(1):17-28. PubMed ID: 9878680
[TBL] [Abstract][Full Text] [Related]
16. Synapses between corticotropin-releasing factor-containing axon terminals and dopaminergic neurons in the ventral tegmental area are predominantly glutamatergic.
Tagliaferro P; Morales M
J Comp Neurol; 2008 Feb; 506(4):616-26. PubMed ID: 18067140
[TBL] [Abstract][Full Text] [Related]
17. Electron microscopic evidence for coexistence of leucine5-enkephalin and gamma-aminobutyric acid in a subpopulation of axon terminals in the rat locus coeruleus region.
Van Bockstaele EJ; Chan J
Brain Res; 1997 Jan; 746(1-2):171-82. PubMed ID: 9037496
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural evidence for co-localization of corticotropin-releasing factor receptor and mu-opioid receptor in the rat nucleus locus coeruleus.
Reyes BA; Glaser JD; Van Bockstaele EJ
Neurosci Lett; 2007 Feb; 413(3):216-21. PubMed ID: 17194545
[TBL] [Abstract][Full Text] [Related]
19. Localization of amyloid beta peptides to locus coeruleus and medial prefrontal cortex in corticotropin releasing factor overexpressing male and female mice.
Ross JA; Alexis R; Reyes BAS; Risbrough V; Van Bockstaele EJ
Brain Struct Funct; 2019 Sep; 224(7):2385-2405. PubMed ID: 31250157
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamic projections to locus coeruleus neurons in rat brain.
Reyes BA; Valentino RJ; Xu G; Van Bockstaele EJ
Eur J Neurosci; 2005 Jul; 22(1):93-106. PubMed ID: 16029199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
